- Home
- CORT vs LEVI Comparison
CORT vs LEVI Comparison
Compare CORT & LEVI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CORT
- LEVI
- Stock Information
- Founded
- CORT 1998
- LEVI 1853
- Country
- CORT United States
- LEVI United States
- Employees
- CORT N/A
- LEVI N/A
- Industry
- CORT Biotechnology: Pharmaceutical Preparations
- LEVI Apparel
- Sector
- CORT Health Care
- LEVI Consumer Discretionary
- Exchange
- CORT Nasdaq
- LEVI Nasdaq
- Market Cap
- CORT 8.1B
- LEVI 6.2B
- IPO Year
- CORT N/A
- LEVI 2019
- Fundamental
- Price
- CORT $71.68
- LEVI $17.10
- Analyst Decision
- CORT Strong Buy
- LEVI Strong Buy
- Analyst Count
- CORT 4
- LEVI 11
- Target Price
- CORT $142.00
- LEVI $20.45
- AVG Volume (30 Days)
- CORT 1.4M
- LEVI 1.9M
- Earning Date
- CORT 05-05-2025
- LEVI 06-25-2025
- Dividend Yield
- CORT N/A
- LEVI 3.04%
- EPS Growth
- CORT 8.36
- LEVI 195.92
- EPS
- CORT 1.14
- LEVI 0.89
- Revenue
- CORT $685,446,000.00
- LEVI $6,401,900,000.00
- Revenue This Year
- CORT $35.85
- LEVI N/A
- Revenue Next Year
- CORT $35.22
- LEVI $4.41
- P/E Ratio
- CORT $62.77
- LEVI $19.28
- Revenue Growth
- CORT 30.93
- LEVI 7.23
- 52 Week Low
- CORT $28.04
- LEVI $12.17
- 52 Week High
- CORT $117.33
- LEVI $24.34
- Technical
- Relative Strength Index (RSI)
- CORT 46.01
- LEVI 50.04
- Support Level
- CORT $74.34
- LEVI $17.17
- Resistance Level
- CORT $80.65
- LEVI $18.53
- Average True Range (ATR)
- CORT 3.81
- LEVI 0.46
- MACD
- CORT -0.19
- LEVI -0.10
- Stochastic Oscillator
- CORT 16.43
- LEVI 12.44
About CORT Corcept Therapeutics Incorporated
Corcept Therapeutics Inc is a commercial-stage pharmaceutical company engaged in the discovery and development of medications that treat severe metabolic, oncologic and neuropsychiatric disorders by modulating the effect of the hormone cortisol. The company's compounds are being evaluated in clinical trials as potential treatments for a variety of serious disorders - hypercortisolism, advanced ovarian cancer, prostate cancer, ALS, and MASH.
About LEVI Levi Strauss & Co
Levi Strauss & Co is involved in designing, marketing, and selling products that include jeans, casual and dresses pants, tops, shorts, skirts, jackets, footwear, and related accessories directly or through third parties and licensees for men, women, and children under Levi's, Dockers, Signature by Levi Strauss & Co. and Denizen brands. The company manages its business according to three regional segments: the Americas, which is the key revenue driver; Europe; and Asia.